The Statins Bandwagon Rolls On

| February 14, 2017

The debate over cholesterol-lowering statins for preventing heart disease has been rumbling on for years. As I wrote here, here and here, evidence shows that statins can cause type 2 diabetes, along with crippling muscle and joint pain, digestive problems, memory loss and premature ageing – and may even cause heart problems, too!

Because of these concerns, many US type 2 diabetes patients and their doctors are now avoiding statins, as I reported here. But, with these drugs being such a huge source of Big Pharma’s profits worldwide, it will do anything to keep the statins bandwagon rolling. So, I read with some scepticism a recently-published paper in which two professors of medicine claim that statins’ link with type 2 diabetes is all a mirage. Or, even if it isn’t, that millions of people will die unless doctors write more prescriptions for statins.

The paper, which was published online in January, is a “commentary” – in other words it reflects the authors’ views, rather than any new research findings.1 They claim that:

  • The link between statins and type 2 diabetes is unproven
  • Even if true, this effect is insignificant when compared with the benefits of statins
  • Statins are under-utilised, particularly by women
  • Wider use of statins will result in fewer heart attacks and strokes
  • Adverse publicity about statin risks and side effects is “ill-advised”

These views ignore the findings from five independent meta-analyses of clinical trials that show a clear increase in diabetes risk, which rises in direct relation to length of statin use and with the potency of the statin being taken. As for the benefits of statins, a 2015 study unveiled the statistical trick used in many trials to make trivial reductions in cardiovascular risks seem much greater.2

And there is no good reason why women should be given more statins. Women who take statins are at an even greater risk of developing type 2 diabetes than men.3 And even with statistical jiggery-pokery, no large-scale trial has yet shown that statins increase life expectancy in women by even one day.

In my next blog post I’ll be looking into the conflicts of interest revealed by the authors of the new paper, and at yet another attempt by Big Pharma to find wider uses for its dangerous statin drugs.

Wishing you the best of health,

Martin Hum
PhD DHD Nutritionist
for Real Diabetes Truth

Bear in mind we are not addressing anyone’s personal situation and you should rely on this for informational purposes only. Please consult with your own physician before acting on any recommendations contained herein.

Sources

  1. Hennekens CH, Teng B, Pfeffer MA. Statins and diabetes: current perspectives and implications for clinicians. Am J Med. 2017 Jan 12 (Online ahead of print).
  2. Diamond DM, Ravnskov U. How statistical deception created the appearance that statins are safe and effective in primary and secondary prevention of cardiovascular disease. Expert Rev Clin Pharmacol. 2015; 8(2):201-210.
  3. Goodarzi MO, Li X, Krauss RM, Rotter JI, Chen YD. Relationship of sex to diabetes risk in statin trials. Diabetes Care. 2013; 36(7):e100-101.

 

Print Friendly

Tags: , , ,

Category: Diabetes News Views

Comments are closed.